entertainment -WSS

entertainment

author：comprehensive 2025-09-06 04:41:37 - browse：148

A nurse prepares to administer chemotherapy treatment. -- Cancer coverage from STAT — Preparing a chemotherapy treatment at Duke Cancer Center in Durham, N.C. Gerry Broome/AP

A young girl, maybe 5 or 6 years old, had come into Yoram Unguru’s clinic with acute lymphoblastic leukemia, the most common of all childhood cancers. One of the drugs needed for treatment was methotrexate. The only problem was that the drug was in short supply.

“Oftentimes we can cure kids of their disease, but we can’t do that without the drugs,” said Unguru, a pediatric hematologist oncologist at Children’s Hospital at Sinai in Baltimore and the Johns Hopkins School of Medicine. “It’s just so, so maddening.”

Methotrexate isn’t the only essential chemotherapy clinicians are having a hard time getting their hands on right now. Two other key chemotherapies, cisplatin and carboplatin, which are also generic injectable drugs, have been in shortage for the last few months. But Unguru didn’t see this particular patient recently or even in the last year. He saw her over a decade ago, when the country was facing a different methotrexate shortage back in 2012.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

hotspot

WSS

How AI can help patients find reliable information about doctors

STAT Summit: How researchers deal with rejection

STAT Readout Newsletter: Biotech news today

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Results on Novartis prostate cancer therapy could expand its use

New research sheds light on how often breast cancer is overdiagnosed

focus

entertainment

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

Cassava Sciences’ Alzheimer’s clinical trials should be halted

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Summit: Ending the crisis of Black deaths in the U.S.

Heart attack and stroke risk calculators need revising

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Alkermes shareholders re

STAT Summit: Ending the crisis of Black deaths in the U.S.

Psychedelics group wrestles with new pharma identity

Roche drug slashes death risk in early

focus

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Stroke rates rising, especially in working

STAT Summit: How researchers deal with rejection

Roivant's CEO is a star, but biotech's black hole persists

Should insurance cover cosmetic surgery?

Cassava Sciences’ Alzheimer’s clinical trials should be halted

hotspot

hotspot

Wikipedia

explore